Subscribe to RSS

DOI: 10.1055/a-2073-3947
Telemedizinische Betreuung von Demenzerkrankten in der COVID-19 Pandemie
Telemedicine Care of Dementia Patients During the COVID-19 Pandemic Funding Information Bundesministerium für Bildung und Forschung — http://dx.doi.org/10.13039/501100002347; WIR!-Bündnis WeCaRe aus der Programmfamilie Innov
Zusammenfassung
In unserem multidisziplinären Gedächtniszentrum der Universitätsklinik Jena haben wir bereits zu Beginn der SARS-CoV2-Pandemie im Frühjahr 2020 mit der regulären Einführung einer Videosprechstunde für Patient*innen mit Risiko für eine Demenzentwicklung bzw. mit einer Demenzerkrankung und deren Angehörigen begonnen.
Über einen Zeitraum von 12 Monaten haben wir eine systematische Befragung zur Zufriedenheit bei Patient*innen im regulären Face-to-Face-Kontakt (F2F) und bei Videokonsultationen (VC) durchgeführt.
Ziel dieser Studie war eine Bewertung der Einsatzmöglichkeiten von Telemedizin bei älteren Menschen mit beginnenden kognitiven Defiziten im Rahmen einer Demenzerkrankung. Dabei wollten wir insbesondere die Patientenzufriedenheit und die Durchführbarkeit bewerten.
Ausgewertet wurden Erstvorstellungen in unserem Gedächtniszentrum bei Verdacht auf das Vorliegen einer demenziellen Erkrankung in einem standardisierten regulären Vorort-Setting (n=50) sowie in einer standardisierten Videokonsultation (n=40). In beiden Settings erfolgten aufeinanderfolgend eine neuropsychologische und eine ärztliche Vorstellung. Beide Gruppen waren bezüglich Alter und Geschlecht ähnlich verteilt (71.4 vs. 72.3 Jahre, 52 vs. 50% weiblich (F2F vs. VC)). Der kognitive Status war in der VC Gruppe leicht besser (ACE III signifikant, MMST nicht signifikant).
In der Befragung der Patient*innen anhand eines Inventars mit 12 Fragen (Patient*innenzufriedenheit, bewertet mit 1 bis 5) zeigte sich zwischen beiden Gruppen insgesamt kein signifikanter Unterschied. Tendenziell wurde hier allerdings der F2F in der Bewertung der Beratung etwas besser bewertet. Der technische Ablauf bei der VC wurde von Ärzt*innen und Neuropsycholog*innen zu über 80% als gut/sehr gut bewertet.
Eine allgemeine Einschätzung der kognitiven Defizite durch Ärzt*innen und Neuropsycholog*innen korrelierte im F2F und VC extrem hoch mit dem Ergebnis der anschließenden spezifischen Testung (MMST und ACE). Bei tendenziell besserer Übereinstimmung im VC war der Unterschied zwischen den Korrelationen nicht signifikant.
Insgesamt konnten wir keinen signifikanten Unterschiede bei der Patient*innenzufriedenheit zwischen VC und klassischer F2F Vorstellung finden. Technische Aspekte in der Vorbereitung einer VC und während einer VC waren weniger problematisch als initial antizipiert.
Abstract
In our multidisciplinary memory center at Jena University Hospital, we initiated a regular video consultation for patients at risk of developing dementia or with dementia disease and their relatives at the beginning of the SARS-CoV2 pandemic in spring 2020.
Over a 12-month period, we conducted a systematic survey of satisfaction among patients in regular face-to-face contact (F2F) and video consultations (VC).
The aim of this study was to evaluate the potential use of telemedicine in older people with incipient cognitive deficits in the context of dementia. In particular, we aimed to evaluate patient satisfaction and feasibility.
Initial presentations to our memory center for suspected dementia were evaluated in a standardized regular on-site setting (n=50) and in a standardized video consultation (n=40). In both settings, a neuropsychologist’s and a physician’s consultation were performed consecutively. Both groups were similarly distributed in terms of age and sex (71.4 vs. 72.3 years, 52 vs. 50% female (F2F vs. VC)). Cognitive status was slightly better in the VC group (ACE III significant, MMST not significant).
In the survey of the patients using a 12-question inventory (patient satisfaction, rated 1 to 5), there was no significant difference between the two groups overall. However, the F2F tended to be rated slightly better here in terms of advice. More than 80% of the physicians and neuropsychologists rated the technical process of VC as good/very good.
A general assessment of the cognitive deficits by physicians and neuropsychologists correlated extremely highly with the results of the subsequent specific testing (MMST and ACE) in F2F and VC. With a tendency to better agreement in VC, the difference between the correlations was not significant.
Overall, we could not find any significant differences in patients’ satisfaction between VC and classical F2F presentation. Technical aspects in the preparation of a VC and during a VC were less problematic than initially anticipated.
Publication History
Received: 20 July 2022
Accepted: 23 March 2023
Article published online:
12 July 2023
© 2023. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).
Georg Thieme Verlag
Rüdigerstraße 14, 70469 Stuttgart,
Germany
-
Literatur
- 1 Adams JL, Myers TL, Waddell EM, Spear KL, Schneider RB. ‘Telemedicine: A Valuable Tool in Neurodegenerative Diseases’. Current Geriatrics Reports 2020; 9: 72-81
- 2 Adorjan K, Haussmann R, Rauen K, Pogarell O. ‘Folgen Der COVID-19-Pandemie Für Menschen Mit Schizophrenie, Demenz Und Abhängigkeitserkrankungen’. Der Nervenarzt 2021; 1-8
- 3 Alonso-Lana S, Marquié M, Ruiz A, Boada M. ‘Cognitive and Neuropsychiatric Manifestations of COVID-19 and Effects on Elderly Individuals With Dementia’. Frontiers in Aging Neuroscience 2020; 12: 588872
- 4 Anon. 2021. ‘WeCaRe – Projekt für eine ganzheitliche Gesundheitsversorgung in strukturschwachen Regionen Mitteldeutschlands – Jena – BMBF Innovation & Strukturwandel’. Bundesministerium für Bildung und Forschung – BMBF Innovation & Strukturwandel. Retrieved 5 September 2022 (https://www.innovation-strukturwandel.de/strukturwandel/de/innovation-strukturwandel/die-initiativen/_documents/artikel/s-z/wecare-projekt-fuer-eine-ganzh-en-regionen-mitteldeutschlands.html)
- 5 Barton C, Morris R, Rothlind J, Yaffe K. ‘Video-Telemedicine in a Memory Disorders Clinic: Evaluation and Management of Rural Elders with Cognitive Impairment’. Telemedicine Journal and E-Health: The Official Journal of the American Telemedicine Association 2011; 17: 789-793
- 6 Bianchetti A, Rozzini R, Guerini F, Boffelli S, Ranieri P, Minelli G, Bianchetti L, Trabucchi M. ‘Clinical Presentation of COVID19 in Dementia Patients’. The Journal of Nutrition, Health & Aging 2020; 24: 560-562
- 7 Ciemins EL, Holloway B, Coon PJ, McClosky-Armstrong T, Min SJ. ‘Telemedicine and the Mini-Mental State Examination: Assessment from a Distance’. Telemedicine Journal and E-Health: The Official Journal of the American Telemedicine Association 2009; 15: 476-478
- 8 Diedenhofen B, Musch J. ‘Cocor: A Comprehensive Solution for the Statistical Comparison of Correlations’. PLoS One 2015; 10: e0121945
- 9 Folstein MF, Folstein SE, McHugh PR. ‘“Mini-Mental State”. A Practical Method for Grading the Cognitive State of Patients for the Clinician’. Journal of Psychiatric Research 1975; 12: 189-198
- 10 Hatcher-Martin JM, Adams JL, Anderson ER, Bove R, Burrus TM, Chehrenama M, Dolan O'Brien M, Eliashiv DS, Erten-Lyons D, Giesser BS, Moo LR, Narayanaswami P, Rossi MA, Soni M, Tariq N, Tsao JW, Vargas BB, Vota SA, Wessels SR, Planalp H, Govindarajan R. ‘Telemedicine in Neurology: Telemedicine Work Group of the American Academy of Neurology Update’. Neurology 2020; 94: 30-38
- 11 Izcovich A, Ragusa MA, Tortosa F, Lavena Marzio MA, Agnoletti C, Bengolea A, Ceirano A, Espinosa F, Saavedra E, Sanguine V, Tassara A, Cid C, Catalano HN, Agarwal A, Foroutan F, Rada G. ‘Prognostic Factors for Severity and Mortality in Patients Infected with COVID-19: A Systematic Review’. PloS One 2020; 15: e0241955
- 12 Jin B, Park N. ‘In-Person Contact Begets Calling and Texting: Interpersonal Motives for Cell Phone Use, Face-to-Face Interaction, and Loneliness’. Cyberpsychology, Behavior and Social Networking 2010; 13: 611-618
- 13 Kishi T, Matsunaga S, Oya K, Nomura I, Ikuta T, Iwata N. ‘Memantine for Alzheimer’s Disease: An Updated Systematic Review and Meta-Analysis’. Journal of Alzheimer’s Disease: JAD 2017; 60: 401-425
- 14 Lai FH, Yan EW, Yu KK, Tsui WS, Chan DT, Yee BK. ‘The Protective Impact of Telemedicine on Persons With Dementia and Their Caregivers During the COVID-19 Pandemic’. The American Journal of Geriatric Psychiatry: Official Journal of the American Association for Geriatric Psychiatry 2020; 28: 1175-1184
- 15 Larner AJ. ‘Cognitive Testing in the COVID-19 Era: Can Existing Screeners Be Adapted for Telephone Use?’. Neurodegenerative Disease Management 2021; 11: 77-82
- 16 Lee JH, Kim JH, Jhoo JH, Lee KU, Kim KW, Lee DY, Woo JI. ‘A Telemedicine System as a Care Modality for Dementia Patients in Korea’. Alzheimer Disease and Associated Disorders 2000; 14: 94-101
- 17 Livingston G, Huntley J, Sommerlad A, Ames D, Ballard C, Banerjee S, Brayne C, Burns A, Cohen-Mansfield J, Cooper C, Costafreda SG, Dias A, Fox N, Gitlin LN, Howard R, Kales HC, Kivimäki M, Larson EB, Ogunniyi A, Orgeta V, Ritchie K, Rockwood K, Sampson EL, Samus Q, Schneider LS, Selbæk G, Teri L, Mukadam N. ‘Dementia Prevention, Intervention, and Care: 2020 Report of the Lancet Commission’. The Lancet 2020; 396: 413-446
- 18 Loh PP. ‘Telemedicine and Alzheimer’s Disease from Studio-Based Videoconferencing to Mobile Handheld Cell Phones’. Journal of Brain Disease 2009; 1: 39-43
- 19 Loh PK, Donaldson M, Flicker L, Maher S, Goldswain P. ‘Development of a Telemedicine Protocol for the Diagnosis of Alzheimer’s Disease’. Journal of Telemedicine and Telecare 2007; 13: 90-94
- 20 Teo WP, Kannan A, Loh PK, Chew E, Sharma VK, Chan YC. ‘Diagnostic Accuracy of Telehealth Community Dementia Assessments’. Journal of the American Geriatrics Society 2005; 53: 2043-2044
- 21 Manca R, De Marco M, Venneri A. ‘The Impact of COVID-19 Infection and Enforced Prolonged Social Isolation on Neuropsychiatric Symptoms in Older Adults With and Without Dementia: A Review’. Frontiers in Psychiatry 2020; 11: 585540
- 22 Mathuranath PS, Nestor PJ, Berrios GE, Rakowicz W, Hodges JR. ‘A Brief Cognitive Test Battery to Differentiate Alzheimer’s Disease and Frontotemporal Dementia’. Neurology 2000; 55: 1613-1620
- 23 McKinley RK, Manku-Scott T, Hastings AM, French DP, Baker R. ‘Reliability and Validity of a New Measure of Patient Satisfaction with out of Hours Primary Medical Care in the United Kingdom: Development of a Patient Questionnaire’. BMJ (Clinical Research Ed.) 1997; 314: 193-198
- 24 McKinstry B, Walker J, Campbell C, Heaney D, Wyke S. ‘Telephone Consultations to Manage Requests for Same-Day Appointments: A Randomised Controlled Trial in Two Practices’. The British Journal of General Practice: The Journal of the Royal College of General Practitioners 2002; 52: 306-310
- 25 Moo LR, Gately ME, Jafri Z, Shirk SD. ‘Home-Based Video Telemedicine for Dementia Management’. Clinical Gerontologist 2020; 43: 193-203
- 26 Morgan DG, Crossley M, Kirk A, McBain L, Stewart NJ, D'Arcy C, Forbes D, Harder S, Dal Bello-Haas V, Basran J. ‘Evaluation of Telehealth for Preclinic Assessment and Follow-Up in an Interprofessional Rural and Remote Memory Clinic’. Journal of Applied Gerontology: The Official Journal of the Southern Gerontological Society 2011; 30: 304-331
- 27 Shores MM, Ryan-Dykes P, Williams RM, Mamerto B, Sadak T, Pascualy M, Felker BL, Zweigle M, Nichol P, Peskind ER. ‘Identifying Undiagnosed Dementia in Residential Care Veterans: Comparing Telemedicine to in-Person Clinical Examination’. International Journal of Geriatric Psychiatry 2004; 19: 101-108
- 28 Smith AC, Thomas E, Snoswell CL, Haydon H, Mehrotra A, Clemensen J, Caffery LJ. ‘Telehealth for Global Emergencies: Implications for Coronavirus Disease 2019 (COVID-19)’. Journal of Telemedicine and Telecare 2020; 1357633X20916567
- 29 Tsapanou A, Papatriantafyllou JD, Yiannopoulou K, Sali D, Kalligerou F, Ntanasi E, Zoi P, Margioti E, Kamtsadeli V, Hatzopoulou M, Koustimpi M, Zagka A, Papageorgiou SG, Sakka P. ‘The Impact of COVID-19 Pandemic on People with Mild Cognitive Impairment/Dementia and on Their Caregivers’. International Journal of Geriatric Psychiatry 2021; 36: 583-587
- 30 Wang H, Li T, Barbarino P, Gauthier S, Brodaty H, Molinuevo JL, Xie H, Sun Y, Yu E, Tang Y, Weidner W, Yu X. ‘Dementia Care during COVID-19’. Lancet (London, England) 2020; 395: 1190-1191
- 31 American Academy of Neurology Telemedicine Work Group. Wechsler LR, Tsao JW, Levine SR, Swain-Eng RJ, Adams RJ, Demaerschalk BM, Hess DC, Moro E, Schwamm LH, Steffensen S, Stern BJ, Zuckerman SJ, Bhattacharya P, Davis LE, Yurkiewicz IR, Alphonso AL. ‘Teleneurology Applications: Report of the Telemedicine Work Group of the American Academy of Neurology’. Neurology 2013; 80: 670-676
- 32 Weiner MF, Rossetti HC, Harrah K. ‘Videoconference Diagnosis and Management of Choctaw Indian Dementia Patients’. Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association 2011; 7: 562-566
- 33 Tso, Jason V., Roxanna Farinpour, Helena C. Chui, and Collin Y. Liu. “A Multidisciplinary Model of Dementia Care in an Underserved Retirement Community, Made Possible by Telemedicine.” Frontiers in Neurology 7 (2016): 225. Doi: 10.3389/fneur.2016.00225
- 34 Powers, Becky B., Marcia C. Homer, Natalia Morone, Natali Edmonds, and Michelle I. Rossi. “Creation of an Interprofessional Teledementia Clinic for Rural Veterans: Preliminary Data.” Journal of the American Geriatrics Society 65, no. 5 (May 2017): 1092–1099. Doi: 10.1111/jgs.14839